Kaneria Mala V, Paul Sonia
Department of Medicine, T.N. Medical College and B.Y.L. Nair Ch. Hospital, Mumbai.
J Assoc Physicians India. 2012 Nov;60:26-8.
Rampant and injudicious use of broad spectrum antibiotics in hospitalized patients has increased the incidence of Clostridium difficile associated diarrhoea (CDAD). Though antibiotic use is the best known risk factor for CDAD, the occurrence of community acquired C. difficile suggests the presence of other risk factors too. However CDAD is still under-recognized in India and Asia. Therefore we undertook a prospective study to determine the incidence of Clostridium difficile associated diarrhoea in our hospital.
50 patients of antibiotic associated diarrhoea (AAD) and 50 age and sex matched controls were studied prospectively over a period of 1 year. Controls were patients on antibiotics who did not have diarrhoea. All other causes of diarrhoea were ruled out. Fresh stool samples were examined for the presence of C. difficile toxin A and B by the enzyme-linked immunofluorescence assay.
5 patients in the AAD group (10%) and 3 patients in the control group (6%) were positive for C. difficile toxin A and B. 5 (10%) patients in the control group showed equivocal results. Out of the 5 CDAD patients, 4 (80%) were males and 1 was a female (p = 2, not significant). 3 patients were from the MICU and 2 were from the medical wards. The median age of the patients was 39 years. Only 1 male patient was > 60 years old (p = 0.781, not significant). All 5 CDAD patients were on proton pump inhibitors (PPIs) and 2 had Ryle's tube inserted (p = 0.22, not significant). Only 2 patients had leucocytosis (p = 1.67, not significant) and none showed faecal leucocytosis. So out of 100 patients on antibiotics, 8 (8%) tested positive for C. difficile toxins in their stools. However, only 5 (5%) had diarrhoea (CDAD) whereas 3 (3%) were asymptomatic carriers.
The incidence of CDAD in our hospital was 10% of the 50 patients with AAD. The asymptomatic carriage rate was 6%. All the cases had mild to moderate diarrhoea and were responsive to metronidazole unlike the west where the incidence is higher and the disease more severe.
住院患者中广泛且不合理地使用广谱抗生素增加了艰难梭菌相关性腹泻(CDAD)的发病率。尽管抗生素使用是CDAD最广为人知的危险因素,但社区获得性艰难梭菌的出现表明还存在其他危险因素。然而,CDAD在印度和亚洲仍未得到充分认识。因此,我们进行了一项前瞻性研究,以确定我院艰难梭菌相关性腹泻的发病率。
对50例抗生素相关性腹泻(AAD)患者和50例年龄及性别匹配的对照者进行了为期1年的前瞻性研究。对照者为使用抗生素但未出现腹泻的患者。排除了所有其他腹泻原因。通过酶联免疫荧光测定法检测新鲜粪便样本中是否存在艰难梭菌毒素A和B。
AAD组中有5例患者(10%)以及对照组中有3例患者(6%)的艰难梭菌毒素A和B检测呈阳性。对照组中有5例患者(10%)结果不明确。在5例CDAD患者中,4例(80%)为男性,1例为女性(p = 2,无统计学意义)。3例患者来自重症监护病房(MICU),2例来自内科病房。患者的中位年龄为39岁。只有1例男性患者年龄大于60岁(p = 0.781,无统计学意义)。所有5例CDAD患者均使用质子泵抑制剂(PPI),2例患者插入了鼻胃管(p = 0.22,无统计学意义)。只有2例患者出现白细胞增多(p = 1.67,无统计学意义),且均未出现粪便白细胞增多。因此,在100例使用抗生素的患者中,8例(8%)粪便中艰难梭菌毒素检测呈阳性。然而,只有5例(5%)出现腹泻(CDAD),而3例(3%)为无症状携带者。
我院CDAD的发病率在50例AAD患者中为10%。无症状携带率为6%。所有病例均有轻度至中度腹泻,且对甲硝唑有反应,这与西方不同,西方的发病率更高且疾病更严重。